62°
Feels Like: 62°
81°
62°
77°
By Kerry Grens NEW YORK (Reuters Health) - Evening primrose oil doesn't reduce the symptoms of the itchy skin problem eczema, accord...
Read More »
By Esha Dey and Ransdell Pierson (Reuters) - Allergan Inc said approval of its Darpin eye drug could be delayed up to two years, pro...
Read More »
By Jessica Dye NEW YORK (Reuters) - Reproductive-rights groups that sued the Food and Drug Administration over access to the "mornin...
Read More »By Julie Steenhuysen CHICAGO (Reuters) - The first-ever drug designed to treat social impairments associated with autism failed to s...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - A change to a U.S. program that provides food and medical visits to many infants, ch...
Read More »By Toni Clarke (Reuters) - U.S. health regulators rejected an experimental drug to treat opioid addiction made by Titan Pharmaceutic...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) -Though long-term hormone replacement therapy has serious health risks, going off the med...
Read More »(Reuters) - Generic drugmaker Actavis Inc bought the global rights to Canadian firm Valeant Pharmaceuticals International Inc's anti...
Read More »By Mette Fraende and Shida Chayesteh COPENHAGEN (Reuters) - Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hop...
Read More »
By Padraic Halpin DUBLIN (Reuters) - Irish government ministers agreed draft legislation on Tuesday to allow for limited access to a...
Read More »
